Telisotuzumab vedotin (teliso-v) monotherapy in patients with previously treated c-Met+ advanced non-small cell lung cancer.

dc.authoridBar, Jair/0000-0002-1224-3646
dc.authoridMoiseenko, Fedor/0000-0003-2544-9042
dc.authorwosidBar, Jair/AAS-5743-2021
dc.authorwosidFilippova, Elena/AAE-2696-2022
dc.authorwosidMoiseenko, Fedor/E-1775-2014
dc.contributor.authorCamidge, D. Ross
dc.contributor.authorMoiseenko, Fedor
dc.contributor.authorCicin, Irfan
dc.contributor.authorHorinouchi, Hidehito
dc.contributor.authorFilippova, Elena
dc.contributor.authorBar, Jair
dc.contributor.authorLu, Shun
dc.date.accessioned2024-06-12T11:23:59Z
dc.date.available2024-06-12T11:23:59Z
dc.date.issued2021
dc.departmentTrakya Üniversitesien_US
dc.descriptionAnnual Meeting of the American-Association-for-Cancer-Research (AACR) -- APR 10-MAY 21, 2021 -- Philadelphia, PAen_US
dc.description.abstract[Abstract Not Available]en_US
dc.description.sponsorshipAmer Assoc Canc Resen_US
dc.identifier.issn0008-5472
dc.identifier.issn1538-7445
dc.identifier.issue13en_US
dc.identifier.urihttps://hdl.handle.net/20.500.14551/26756
dc.identifier.volume81en_US
dc.identifier.wosWOS:000680263501335en_US
dc.identifier.wosqualityQ1en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isoenen_US
dc.publisherAmer Assoc Cancer Researchen_US
dc.relation.ispartofCancer Researchen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subject[No Keywords]en_US
dc.titleTelisotuzumab vedotin (teliso-v) monotherapy in patients with previously treated c-Met+ advanced non-small cell lung cancer.en_US
dc.typeConference Objecten_US

Dosyalar